Clinical trial
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue…
NCT00053794 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00053794 |
|---|---|
| Title | Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma |
| Official title | A Phase II Study Of Perifosine (D-21266) In Patients With Previously Untreated Metastatic Or Locally Advanced Soft Tissue Sarcoma |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer, Sarcoma |
| Intervention type | Drug |
| Interventions | perifosine |
| Enrollment | 17 |
| Start date | Jun 9, 2003 |
| Primary completion | Sep 18, 2004 |
| Completion | Sep 22, 2008 |
| First posted | Feb 6, 2003 |
| Last update posted | Aug 4, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: